News

...

...

...

...

...

...

...

ECRIN is thrilled to share its brand new website. This has been in the works for some time and it is with great pleasure that today we finally unveil this new chapter for ECRIN and its outreach....

...

...

The European Joint Programme on Rare Diseases launches today the Joint Transnational Call 2023, a funding opportunity for research projects on the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases....

...

...

...

...

...

...

...

...

...

The ERIC Forum is has released its third policy report ”Assessing the socio-economic impact of ERICS...

Networking workshop “Identifying obstacles hindering the development of academic sponsored trials for drug repurposing on rare diseases”...

A two-day workshop and networking event in Prague...

...

...

The next EUPATI Fundamentals training is taking place online on 14 and 15 November 2022 (10:00 - 16:00 CET each day)....

The recently signed strategic partnership between ECRIN and EUPATI, has been taken to the next level by the election of Christine Kubiak, ECRIN’s Operations Director, as Board member at EUPATI....

...

...

...

...

...

...

...

...

...

...

...

The call for application to ECRIN Data Centre Certification Programme is open until the 23 September 2022....

ECRIN and its national partners are working on a training series that will focus on supporting researchers to develop proposals for European calls that are open to multinational trials....

ISIDORe just launched the first call for transnational access for projects focusing on SARS-CoV-2 and COVID-19 research. ISIDORe TNA programme aims at supporting scientists by providing them access …...

In January 2022 Ecraid became a legal entity and is now fully operational to advance knowledge in the field of infectious diseases. This represents Ecraid’s first step as it evolves into a self-sustaining, not-for-profit organisation conducting clinical research for both public and private sponsors....

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc maximus, nulla ut commodo sagittis. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc maximus, nulla ut commodo sagittis, sapien dui mattis dui, non pulvinar lorem felis nec erat....

...

...

TRANSVAC2, an European vaccine research and development (R&D) infrastructure project, is dedicated to accelerating the development of safe, effective and affordable vaccines. Developing a vaccine is…...

ECRIN supports clinical trials across borders. How do we do that? We are very proud to show it to you in our brand new video! ECRIN is a public, non-profit organisation that links scientific partners…...

The EU-SolidAct trial, previously authorized under the EU CT Directive 2001/20/EC, has been successfully transferred and is authorized under the new EU regulation (Regulation (EU) No 536/2014) in 12…...

After more than 2 years, our partner EUPATI organises the Fundamentals in a face to face session. EUPATI Fundamentals is a training about Patient Engagement addressed to professionals in academia and…...

The MACUSTAR project has received a second Letter of Support from the European Medicines Agency (EMA) for its work on new measures to assess the eye disease age-related macular degeneration in…...